The androgen receptor (AR) is generally considered an autoregulated protein. However, studies in brain have produced mixed results regarding sex differences, which should be present given the higher endogenous levels of androgens in males, and the effects of gonadectomy, which presumably should lead to a loss of AR. Resolving these issues is a necessary step in developing a model of AR regulation in the central nervous system and, more broadly, in determining how regulation of this receptor may mediate neural target tissue responsiveness to androgen. To further investigate these issues, the distribution, density, and regulation of neural AR were compared among male and female mice that were intact, gonadectomized, or gonadectomized and given testosterone propionate (TP) through immunocytochemical and Western blot analyses. Four brain areas that have been linked to the regulation of male-typical behavior were evaluated: bed nucleus of the stria terminalis, posterior aspect, medial preoptic area, and dorsal and ventral aspects of the lateral septum. In the immunocytochemical study, integrated particle density, which reflects the average intensity of AR staining, was assessed among the six groups 24 h after surgery using PG-21, a peptide-based AR antiserum. Major findings included regional differences in the intensity of immunostaining; a robust sexual dimorphism in each region, with males exhibiting more intense staining than females; a loss of AR in both sexes after gonadectomy, with more dramatic changes evident in males; and significant up-regulation of AR in response to TP that was equivalent in both sexes. The Western blot analyses of AR in limbic system extracts prepared from the six groups showed a pattern of differences that mirrored the immunocytochemical results, indicating that PG-21 recognized both liganded and unliganded AR. In addition, a dose-response study, in which gonadectomized males and females were administered from 25-1000 g TP, demonstrated a significant linear trend in up-regulation of AR in both males and females, with no sexual dimorphism in the response to hormone treatment. These results demonstrate that the regulation of AR in both male and female neural tissue is comparable and that the critical determinant of AR expression is the presence or absence of androgen. (Endocrinology 139: 1594 -1601, 1998) 
six groups 24 h after surgery using PG-21, a peptide-based AR antiserum. Major findings included regional differences in the intensity of immunostaining; a robust sexual dimorphism in each region, with males exhibiting more intense staining than females; a loss of AR in both sexes after gonadectomy, with more dramatic changes evident in males; and significant up-regulation of AR in response to TP that was equivalent in both sexes. The Western blot analyses of AR in limbic system extracts prepared from the six groups showed a pattern of differences that mirrored the immunocytochemical results, indicating that PG-21 recognized both liganded and unliganded AR. In addition, a dose-response study, in which gonadectomized males and females were administered from 25-1000 g TP, demonstrated a significant linear trend in up-regulation of AR in both males and females, with no sexual dimorphism in the response to hormone treatment. These results demonstrate that the regulation of AR in both male and female neural tissue is comparable and that the critical determinant of AR expression is the presence or absence of androgen. (Endocrinology 139: 1594 -1601, 1998) T HE FUNCTION and integrity of the androgen receptor (AR), which is considered an autoregulated protein, are generally thought to depend on adequate circulating levels of androgen (1) (2) (3) (4) . However, immunochemical studies conducted since 1990 that examined castration/androgen replacement effects in males and sex differences in AR have yielded mixed results regarding this concept. For example, in adult male rat, opossum, and mouse brain, AR levels were either very low or undetectable 1 or 4 days postcastration (the two time points sampled) in all regions that were evaluated, and androgen replacement up-regulated AR in anywhere from 15 min to 24 h after hormone treatment (5) (6) (7) (8) . In guinea pig, however, there was no effect on neural AR immunoreactivity 4 days after males were gonadectomized (9) , and in hamsters, castration produced either a loss of nuclear AR (10) or no effect on immunoreactivity, except in lateral septum, where enhanced staining was noted (11) . Lastly, the retrodorsal nucleus of the spinal cord required substantially longer exposure to testosterone (T) than either the dorsolateral nucleus or spinal nucleus of the bulbocavernosus for the induction of AR after androgen treatment (5) .
Concerning sex differences, the intensity of AR immunostaining was greater in intact male vs. female rats in the posterior bed nucleus of the stria terminalis (BST p ) and periventricular nucleus, but not in the lateral septum (12) , whereas in spinal motoneurons, qualitative immunostaining intensity did not differ between males and females (13) . Using the number of positively labeled cells as an index, no significant sex difference was found between male and female cynomolgus monkeys in seven major limbic system areas, although possible differences in staining intensity were not reported (14) . In mouse brain, a random sample of intact male and female mice (n ϭ 3/group) was compared, and pronounced sex differences (malesϾ Ͼfemales) were found in the intensity of AR immunoreactivity in all receptor-positive regions using integrated particle density as a semiquantitative measure (15) .
These mixed results have led to the suggestion of regional and/or species differences in neural AR regulation (5, 14, 16, 17) . However, concerns about the properties of different AR antisera have limited efforts to resolve these issues. In particular, whether PG-21, the most widely used antiserum, recognizes unliganded AR remains a question (5, 6, 8, 18) , which makes the interpretation of immunochemical findings regarding the effects of castration problematic. As a consequence, it is difficult to conceptualize how neural AR regulation may be, for example, linked to behavioral sensitivity to androgen.
In the present study, the effects of castration with or without T replacement on AR expression were assessed in male and female mouse brain in four regions that have been implicated in the regulation of male-typical behaviors: BST p , medial preoptic area (MPO), and dorsal and ventral aspects of the lateral septum (LS D , and LS V , respectively) (see reviews in Refs. 7 and 19). Including females provided an immunocytochemical assessment of potential sexual dimorphisms in AR regulation that has not previously been reported and may be important for understanding a cellular mechanism linked to androgen sensitivity. The male-female comparisons are a useful model for assessing the latter, because there is a robust sex difference in behavioral sensitivity to androgen (reviewed in Ref. 7) . Western blot analyses were conducted with brain extracts prepared from comparably treated males and females to provide an additional test of quantitative differences in AR. The findings demonstrated that although there is a sexual dimorphism in AR density, regulatory responses to both gonadectomy and T treatment are essentially identical in both sexes.
Materials and Methods

Animals and treatments
Adult CF-1 mice (8 weeks old) were purchased from the Charles River Laboratories (Wilmington, MA). They were housed in groups of three or four per cage at 23 Ϯ 2 C under a 12-h light, 12-h dark cycle, with food and water provided ad libitum. All maintenance procedures fully complied with federal guidelines for animal care. Six groups were included in the immunocytochemistry (ICC) and Western blot studies: females and males that were intact (INT-F and INT-M), gonadectomized (GDX-F and GDX-M), or gonadectomized and treated with T propionate (TP; GDX-FϩT and GDX-MϩT). In the ICC study, a single supraphysiological dose of TP (1000 g) was used. In the subsequent Western analyses, from 25-1000 g TP were administered to test for dose-response effects and whether changes in AR immunoreactivity were consistent across a range of doses. The hormone was injected sc in 0.1 ml oil vehicle immediately upon completion of surgery. Three independent determinations were made for each dose in each sex.
Reagents
Rabbit AR antiserum (PG-21) was a generous gift from Dr. Gail Prins. The ABC staining kit was obtained from Vector Laboratories (Burlingame, CA). Precast minigels, nonfat milk, and biotin-labeled mol wt standards were purchased from Bio-Rad (Hercules, CA). Horseradish peroxidase-conjugated antirabbit antiserum, nitrocellulose membranes, enhanced chemiluminescence (ECL) detection reagents, and Hyperfilm were obtained from Amersham (Arlington Heights, IL). TP was purchased from Steraloids (Wilton, NH). Hemo De and Permount medium were obtained from Fisher Scientific (Fairlawn, NJ). All other reagents were obtained from Sigma Chemical Co. (St. Louis, MO).
ICC
Twenty-four hours after the injection of TP, mice were anesthetized and perfused with PBS, followed by 4% formaldehyde in PBS. The brains were postfixed for 24 h in the same fixative, and 40-m frozen sections were cut on a rotary microtome. Sections were treated with 0.15% Triton X-100/PBS for 40 min, then with 10% FBS/PBS for 30 min. Free floating sections were incubated for 48 h at 4 C in 1% BSA/PBS containing a peptide-based polyclonal AR antiserum against N-terminal amino acids 1-21 (1 g/ml). The sections were washed and placed in biotinylated goat antirabbit IgG solution (1:400) for 2 h, washed in PBS, and then incubated in avidin-biotin-peroxidase complex solution (prepared according to the manufacturer's instructions) for 2 h. Nickel (0.16%)-intensified diaminobenzadine (1 mg/ml) was used as the chromogen. After ICC staining, sections were mounted on gelatin-treated glass slides, air-dried, dehydrated through a graded ethanol series, cleaned in Hemo De, and coverslipped with Permount medium. Although PG-21 is a fully characterized AR antiserum (20) , these were the initial studies with mouse brain, and control procedures that included excess unlabeled peptide and exclusion of primary antiserum were run. Staining was absent under these conditions in all sections (not shown).
Image analysis
Sections were matched across the six groups according to the method of Slotnick and Leonard (21) . For each region, sections were prepared from at least three animals. Images were taken with a CCD-72 video camera connected to a Macintosh computer equipped with an AG-5 Scion frame grabber at a magnification of 20 ϫ 3.3 using an Olympus BH-2 microscope. Measurements of staining intensity were taken in a matched 725 ϫ 725-m field in each area after the images were thresholded by density slicing to the same value. The mean background density for each image was determined after density slicing the background area and was used as a correction factor. Data generated by this approach include the total area of stained particles and mean particle density, which were used for calculating integrated particle density (IPD), defined by the following formula: IPD ϭ total area of stained particles ϫ (mean particle density Ϫ mean background density). The IPD measure provided a semiquantitative index of average staining intensity within a given region and was used as the unit of analysis. A similar approach for comparing AR immunostaining across brain regions was employed by Menard and Harlan (17) .
Western blot and ECL detection
Twenty-four hours after gonadectomy and hormone administration, the animals were killed by cervical dislocation, and blocks containing the regions included in the ICC analysis plus hypothalamus (which also exhibited strong AR staining in the presence of T; data not shown) were isolated from the rest of the brain and minced on an iced stage. Tissues were then placed in 10 mm Tris (pH 7.4), 0.12 m sucrose, 2.5 mm MgCl 2 , 5% SDS, 1 mm phenylmethylsulfonylfluoride, and 0.02% NaN 3 and sonicated. Samples were then boiled for 7 min to denature proteins and reduce proteinase activity and were centrifuged at 7000 rpm for 2 min to pellet any undissolved debris. Supernatants were saved, and protein concentrations were quantitated using the Bio-Rad protein assay method. Each sample was adjusted to 60 g total protein before loading. Proteins were separated on Bio-Rad precast 10% polyacrylamide mini gels. The buffers and electrophoresis procedure have been described previously (22) . Proteins were transferred to nitrocellulose membranes by electroblotting. For immunoblot detection the Amersham ECL detection system was used. In brief, blots were blocked with 5% dry milk in TBS buffer (20 mm Tris, pH 7.6; 137 mm NaCl; and 0.1% Tween-20) for 1 h, transferred into TBS buffer containing 1% dry milk and 0.1 g/ml PG-21 primary antiserum, and incubated for 1 h followed by washes with TBS. Blots were then treated with horseradish peroxidase-conjugated antirabbit IgG diluted in TBS buffer containing 1% dry milk for 1 h and again washed. Finally, blots were reacted with ECL detection reagents, and exposed to Hyperfilm for 1 h. Films were processed with Kodak GBX developer and fixative (Eastman Kodak, Rochester, NY). The area and intensity of each band were quantitated using NIH Image (version 1.59) installed in an Apple Macintosh IIvx computer connected to a Fotodyne photographic system (Fotodyne Inc., Hartland, WI). Three independent replicates were run in each sex at each dose. Preliminary studies showed that the presence of excess peptide completely blocked the immunoreactive bands (not shown).
Data analysis
A two-way ANOVA was used to assess general trends in the ICC results. A series of one-way ANOVAs was conducted to provide more detailed information about effects within each group and each region. The Western blot results were evaluated using ANOVA and trend analysis. In all cases, post-hoc comparisons used Duncan's new multiple range test with ␣ ϭ 0.05.
Results
ICC
In general, positive AR immunostaining was restricted almost exclusively to cell nuclei in all groups and regions. Cytoplasmic staining was not seen in intact or TP-treated animals. In gonadectomized males and females, there was a significant reduction in the intensity of nuclear staining, and a concomitant increase in cytoplasmic staining was not observed. When detected, the levels of reaction product were very low in this compartment.
The results are shown graphically in Fig. 1 , and a representative series of sections is presented in Fig. 2 . This pattern of group differences was consistent within each of the areas analyzed. A two-way ANOVA showed that there were significant differences among the six groups in the density of AR staining independent of region [F(5,124) ϭ 252; P Ͻ 0.001]. Duncan's multiple range test demonstrated the INT-M, GDX-FϩT, and GDX-MϩT groups did not differ from each other, but exhibited significantly greater staining intensity than the INT-F, GDX-F, and GDX-M animals (P Ͻ 0.05; the latter groups also did not differ from each other). There also were significant overall differences in AR immunostaining among the four regions Post-hoc comparisons showed that the GDX-MϩT group exhibited significantly higher immunoreactivity than all other groups. GDX-FϩT and GDX-MϩT did not differ from each other, but were significantly higher than INT-F, GDX-M, and GDX-F. Significantly greater immunoreactivity was seen in INT-F than in GDX-M and GDX-F, and these latter two groups did not differ from each other. Fig. 1 showed that there were significant differences in AR immunoreactivity among the four regions [F(3,20) ϭ 4.09; P Ͻ 0.05]. The intensity of AR-positive staining was highest in BST P and was significantly greater than that seen in LS D and MPO, but not in LS V . The AR-positive staining intensity was significantly higher in the latter region than in LS D . Values in the MPO and LS D did not differ from each other.
Intragroup effects
INT-M. ANOVA of the results summarized in
INT-F.
There were no significant differences in the density of AR staining across the four regions [F(3,20) ϭ 3.05; P ϭ NS].
GDX-M.
The ANOVA showed significant overall differences among the four regions [F(3,20) ϭ 7.97; P Ͻ 0.01]. Post-hoc comparisons revealed that IPD was significantly greater in LS v than in the other regions. Values in BST p , LS D , and MPO did not differ significantly from each other. Fig. 1 showed that there were no significant differences in the density of GDX-MϩT. There were significant regional differences in AR immunoreactivity [see Fig. 1; F(3,20) GDX-FϩT. ANOVA revealed significant differences in AR density among the regions [F(3,20) ϭ 7.35; P Ͻ 0.01]. Post-hoc comparisons showed that AR immunoreactivity in LS V and BST p did not differ, whereas staining intensity was significantly greater than in LS D . The LS V also was significantly higher in IPD than MPO.
GDX-F. ANOVA of the results summarized in
Western blot
The results are shown in Fig. 3 . A dominant 97-kDa band, which was regulated by androgen, was detected in all groups. The values reflect the integrated density of this band, which was calculated by multiplying intensity ϫ area. A two-way ANOVA showed that there was a significant sex difference in the optical density of the AR band [F(1,32) ϭ 8.9; P Ͻ 0.01]. As shown in the histogram, this effect was due primarily to the difference in normal and residual AR band densities in males and females when intact and after castration, respectively. The induction of AR in both sexes 24 h after exogenous TP administration was essentially identical. There also was a significant difference among the dosages independent of sex [F(6,32) ϭ 22.9; P Ͻ 0.01], whereas the sex ϫ treatment interaction was not significant [F(6,32) ϭ 1.18; P ϭ NS]. Trend analyses were employed to assess whether there was a linear response to the increasing doses of TP (in this analysis, data from the intact animals were excluded because of the sex difference in endogenous circulating androgen). In both males and females, a significant linear trend was evident through the 1000-g dose [males: F(1,12) ϭ 33.62; P Ͻ 0.001; females: F(1,12) ϭ 49.81; P Ͻ 0.001], demonstrating that AR can be induced beyond levels seen in intact males in neural tissue. A second band at approximately 55 kDa also was detected (not shown). The identity of this band is unclear, because integrated density did not differ significantly among the groups, which would have been expected if the band represented a proteolytic fragment of the receptor.
Discussion
Four findings in this study extend previous investigations of neural AR regulation. One was the sexual dimorphism in AR immunoreactivity, which was observed in all four regions. This result is basically consistent with those reported in rats, with the exception of the lateral septum, where no difference was found between males and females (12) . The discrepancy can be explained by differences in analytical methods, specifically the use of positively labeled cells vs. the integrated density of AR immunostaining. Perhaps more important was the observation of comparable regulation of AR in males and females after androgen administration. Although other studies also have shown up-regulation of AR by androgen in male brain in 24 h or less (5, 6, 8, 10) , the present results are the first to demonstrate androgen-depen-dent regulation of AR in female brain in a manner essentially identical to that seen in males. This finding has implications for models of sex differences in neural target tissue sensitivity to androgen. Third, the consistency of castration and T-induced effects in both the ICC and Western blot analyses is noteworthy. Fourth, there was a linear increase in AR in response to TP in both males and females at doses up through 1000 g. Androgen receptor band densities in both females and males exceeded those seen in intact males at all doses above 50 g. This significant induction of AR was specifically dependent on androgen, because flutamide, an antiandrogen, did not increase AR density beyond that seen in castrated males at comparable doses (Lu, S., and N. G. Simon, unpublished data). A similar enhancement of the AR protein level was noted in several brain regions in intact male rats after 14 days of exposure to anabolic androgens (7), in spinal nuclei in castrated males 8 h after a 2-mg TP injection (5), and in castrated European male ferrets after 10 days of T treatment (16) . These observations bear on a number of issues raised by recent immunochemical and regulatory studies of neural AR, including whether PG-21 recognizes unliganded receptor, the suggestion of region-specific differences in AR regulation, and, more broadly, whether changes in AR density contribute directly to neural sensitivity to androgen.
Previous efforts to understand neural AR regulation in males had led to the suggestion that PG-21 did not recognize unliganded AR (5, 6, 8, 18) . This position was derived from observations of AR after androgen withdrawal or treatment in, for example, BST and several androgen-responsive spinal nuclei and conflicting reports on whether castration did or did not cause a loss of AR immunoreactivity in neural target cells (c.f. Ref. 10 vs. Ref. 11 ). The present study, by combining both ICC and Western blot analyses, provides some insight into this question. The former consistently showed a loss of AR immunoreactivity 24 h after castration in both males and females in the four regions reported and has been observed throughout the mouse brain (Lu, S., and N. G. Simon, unpublished observations). Because the Western analyses yielded ratios of AR band densities that mirrored the ICC data, it seems reasonable to conclude that the loss of immunoreactivity in gonadectomized animals in the ICC study reflected a steep decline in AR protein levels rather than an inability of PG-21 antiserum to detect unoccupied AR. More specifically, if unoccupied receptor conformation in situ had made the targeted epitope unavailable for antibody recognition and thus caused the decreased staining in the ICC experiment, then the Western blot analyses, where proteins were denatured, would have shown more intense AR bands in the gonadectomized male and female conditions. Combined, these observations suggest that there is a rapid loss of AR in neural target tissue as circulating androgens decrease, which also has been seen in peripheral tissues such as ventral prostate (23, 24) , and that androgen serves to stabilize the receptor. Support for the latter is seen in biochemical studies that showed an effect of ligand on AR half-life (1, 25, 26) . One implication of this perspective about AR loss in the absence of androgen is that earlier equilibrium binding studies that used an interval of 24 h or more after castration before conducting the assays may have underestimated the normal endogenous AR population (27) (28) (29) (30) . Exchange assays thus appear to be necessary for accurate quantitation of AR (31, 32) .
Males and females exhibited comparable responses to go- nadectomy and TP replacement, which bears on the question of whether AR regulation by androgen is a factor in the sexual dimorphism in neural and behavioral sensitivity to androgen. The effects were similar across the four regions, particularly in response to TP treatment. Dose-response effects did not differ between males and females in the Western analyses; there was a linear response to the increasing level of androgen. These observations demonstrate that there is a common regulatory mechanism for AR in male and female neural tissue in mice and that the major factor is the presence or absence of androgen, findings that are consistent with autoregulation of AR by androgen. The progressive increase in AR band density that accompanied higher TP doses demonstrates that augmentation of AR levels is possible and is in keeping with recent immunochemical results. In one of these studies, AR expression also was increased beyond that seen in normal males 24 h after treatment (5), whereas in the other, enhanced AR levels were found 14 days after exposure to an anabolic androgen cocktail (17) . Because androgen binding slows receptor degradation and extends the AR complex half-life (1, 26) , it is likely that stabilization of AR is a contributing factor in the up-regulation of receptor levels. At the same time, de novo AR synthesis is required for a constant supply of receptor protein (23) . Given that AR functions as a transcription factor, it is likely that alterations in its cellular level have direct effects on target gene expression. The augmentation of AR levels and the significant upregulation of this protein within 24 h of androgen administration have implications for efforts to understand behavioral changes associated with anabolic steroid abuse and mechanisms underlying neural target tissue sensitivity to androgen. Extended exposure to anabolic steroids has been linked to a set of personality changes, including "roid rage" (33) (34) (35) . The elevated levels of AR seen in response to higher doses of androgen may represent part of the cellular events that underlie these changes. In this context, chronic, high level anabolic androgen treatment significantly increased the aggressiveness of pubertal male hamsters (36) and the optical density of AR in rat brain (17) . At the same time, the comparable increases in AR immunoreactivity in females and males suggest that changes in the level of this protein are not sufficient to produce parallel changes in behavioral sensitivity to androgen. A prominent example of this dissociation is the induction of male-typical aggression in adult female mice. The activation of this response in females is a direct, androgen-dependent effect (37) (38) (39) . Sixteen to 21 days of androgen exposure were required before aggression toward a stimulus male was seen, yet the present results showed that AR levels were dramatically increased in females within 24 h. This suggests that changes in AR content alone are not sufficient for the induction of male-typical behaviors. Rather, increased cellular AR content probably triggers progressively enhanced (or suppressed) transcription of other androgen-regulated genes (40) , which, in combination, lead to the expression of behaviors such as aggression. A comparable view regarding the lack of a simple relationship between AR immunoreactivity and responsiveness to the masculine sexual behavior-promoting effect of T recently was expressed based on work in male hamsters (41), although it was noted that aromatization of T to estradiol was a cautionary factor in their conclusions.
Three additional issues require attention. One is the observed molecular weight of AR (97 kDa), the second is the absence of any apparent regional differences in AR regulation, and the third is the apparent lack of cytoplasmic immunostaining. Regarding the mol wt, 97 kDa is consistent with that expected based on the derived amino acid sequence for AR (4, 42) . In addition, Puy et al. (43) isolated human neural AR from temporal lobe, and Western analysis demonstrated that it was a 98-kDa protein. However, other investigators have reported AR as an approximately 110-kDa molecule (44 -46) . Although explanations for this modest discrepancy probably include differences in extract preparation and electrophoresis conditions, the most important points are that the 97-kDa protein observed in the Western-ECL blots was immunoreactive with PG-21, a fully characterized anti-AR antiserum, and that this band was selectively regulated by androgen. Regional differences in AR regulation were not observed, at least qualitatively. This should be viewed in the context of the 24-h sampling point used in the study. Caution is necessary before generalizing this finding, however, because other groups have found regional variation in up-regulation at shorter or longer intervals using different measurement systems and when comparing animals before and after puberty (5, 17, 47, 48) . Future work that examines multiple time points and uses directly comparable analytical methods can help clarify this issue. Third, cytoplasmic staining was not detected in intact or T-treated males and females and was negligible in the castrated groups. This observation indicated that the decreased intensity of nuclear immunoreactivity seen 24 h after castration was due to a loss of AR, a conclusion strongly supported by the Western blot results. In this context, increased cytoplasmic immunostaining has been reported 2 weeks or more postcastration (10, 11) , and others have noted some staining in this compartment (5, 49) . Although the former is not inconsistent with the present results because of the intervals employed, the latter may be due to species, tissue, or methodological considerations.
In closing, a pronounced, androgen-dependent sexual dimorphism in endogenous AR populations was described in four regions of the mouse brain. This sexual dimorphism was not due to an inability of PG-21 to recognize unliganded AR, because Western blot analyses showed effects on AR expression that were fully consistent with the ICC findings. The central role of androgen as a determinant of AR expression was demonstrated in both male and female neural tissue. Finally, the virtually identical effects of androgen administration on the level of immunoreactivity in both sexes indicate that there is a common mechanism of AR regulation in mouse brain.
